European Archives - Page 327 of 1375 - European Medical Journal

EMJ Microbiology & Infectious Diseases 6 [Supplement 2] 2025

The possibility of ending the HIV epidemic in Europe is more tangible than ever, but the actions we take now will determine whether we go…

Ending the HIV Epidemic

The possibility of ending the HIV epidemic in Europe is more tangible than ever, but the actions we take now will determine whether we go…

Pulse Wave Velocity Identified as Key Marker of Vascular Ageing

Arterial stiffness, measured by pulse wave velocity, is more strongly linked to ageing than short-term blood pressure variability.

Evaluating Pembrolizumab in First-Line Urothelial Carcinoma Treatment

The results suggest trends towards overall survival and progression-free survival improvements with pembrolizumab in combination with platinum-based chemotherapy.

Pirfenidone for Pulmonary Fibrosis May Also Reduce Lung Cancer Risk

A large-scale study suggests that pirfenidone use in patients with idiopathic pulmonary fibrosis may be linked to a lower incidence of lung cancer.

Heather McArthur

Onc Now: Episode 12: The Future of Breast Cancer Immunotherapy

Heather McArthur, Associate Professor in the Department of Medicine at University of Texas, UT Southwestern Medical Center, discusses recent advancements in breast cancer immunotherapy, and the future of personalised care.

AI System Shows Promise in Detecting Breast Cancer via Abbreviated MRI: ECR 2025

The system, which analyses high-risk screening and diagnostic MRI scans, was tested on datasets from five hospital groups across different countries.

Google’s AI Smartwatch Detects Cardiac Arrest with High Accuracy

Google researchers developed a smartwatch algorithm that detects cardiac arrest with high accuracy, potentially improving survival rates.

The word spotlight on a blue background

Spotlight: February 2025

From a historic vaccine approval to a $50bn investment reshaping US drug manufacturing, February brought major pharma news to the fore.

Sickle Cell Disease Therapies Remain Underused Despite Proven Benefits

Recent research highlights the significant underuse of disease-modifying therapies for sickle cell disease, despite their established benefits in reducing pain and preventing organ damage.